Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.21M Sell
8,009
-7,106
-47% -$2.24M 0.09% 234
2026
Q2
$4.76M Buy
15,115
+153
+1% +$48.2K 0.19% 113
2026
Q1
$4.91M Sell
14,962
-85
-0.6% -$30.5K 0.22% 90
2025
Q4
$5.29M Buy
15,047
+1,808
+14% +$659K 0.23% 89
2025
Q3
$4.89M Buy
13,239
+151
+1% +$58.3K 0.35% 49
2025
Q2
$5.18M Buy
13,088
+515
+4% +$193K 0.41% 45
2025
Q1
$4.68M Buy
12,573
+191
+2% +$72.7K 0.41% 43
2024
Q4
$4.46M Buy
12,382
+6,619
+115% +$2.45M 0.37% 50
2024
Q3
$2.08M Buy
+5,763
New +$1.99M 0.18% 108

Other funds holding SYK

BFC Planning's SYK Position: Q3 2026 in Review

BFC Planning reduced its Stryker (SYK) stake by 47% in Q3 2026, selling an estimated $2.24M and leaving 8,009 shares worth $2.21M. The position accounts for 0.09% of the portfolio, ranked #234.

BFC Planning first reported a position in SYK in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.29M in Q4 2025. 1,898 funds tracked by Wall St. Rank hold SYK as of Q3 2026.

  • BFC Planning held 8,009 shares of Stryker worth $2.21M as of Q3 2026.
  • BFC Planning sold 7,106 Stryker shares in Q3 2026, an estimated $2.24M.
  • Stryker made up 0.09% of BFC Planning's portfolio in Q3 2026, its #234 holding.
  • BFC Planning first reported a position in Stryker in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Stryker position peaked at $5.29M in Q4 2025.
  • 1,898 funds tracked by Wall St. Rank held Stryker as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.